The Limited Usefulness of the Treadmill Test or a Risk-guided Approach in Screening for Asymptomatic Coronary Heart Disease in Japanese Patients with Type 2 Diabetes

Internal Medicine

Volumn 51, Issue 24, 2012, Pages 3337-3342

  Kawasaki Ogita, Yukiko ^a   Hamamoto, Yoshiyuki ^a   Honjo, Sachiko ^a   Ikeda, Hiroki ^a   Wada, Yoshiharu ^a   Nomura, Kazuhiro ^a   Iwasaki, Yorihiro ^a   Nohara, Ryuji ^a   Koshiyama, Hiroyuki ^a,b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Asymptomatic; Coronary heart disease; Diabetes; Screening

Indexed keywords

ARTICLE; ASIAN; ASYMPTOMATIC DISEASE; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; EXERCISE TEST; FEMALE; HUMAN; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK ASSESSMENT;

ASIAN CONTINENTAL ANCESTRY GROUP; ASYMPTOMATIC DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84878225371     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7878     Document Type: Article

References (29)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229–234, 1998.
2. Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hi-sayama Study. Diabetes 45: S14-S16, 1996.
3. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 35: 319–328, 2008.
4. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26: 1553–1579, 2003.
5. Castells I, Salinas I, Rius F, et al. Inducible myocardial ischaemia in asymptomatic Type 2 diabetic patients. Diabetes Res Clin Pract 49: 127–133, 2000.
6. Prior JO, Monbaron D, Koehli M, et al. Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging 32: 60–69, 2005.
7. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45: 43–49, 2005.
8. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 27: 1954–1961, 2004.
9. Janand-Delenne B, Savin B, Habib G, et al. Silent myocardial ischemia in patients with diabetes. Diabetes Care 22: 1396–1400, 1999.
10. Faglia E, Favales F, Calia P, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 25: 2032–2036, 2002.
11. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care 21: 1551–1559, 1998.
12. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high risk asymptomatic diabetic patients who are candidates for screening stress singlephoton emission computed tomography imaging. J Am Coll Cardiol 4: 43–49, 2005.
13. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47: 65–71, 2006.
14. Wackers FJ, Chyun DA, Young LH, et al.; DIAD Investigators. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. Diabetes Care 30: 2892–2898, 2007.
15. Chaitman BR. Exercise stress testing. In: Braunwald's Heart Disease. 6th ed. Braunwald E, Zipes DP, Libby P, Eds. Saunders, Philadelphia, 2001: 129–155.
16. Bax JJ, Young LH, Frye RL, et al. Screening for coronary artery disease in patients with diabetes. Diabetes Care 30: 2729–2736, 2007.
17. Kageyama S, Taniguchi I, Tanaka S, et al. A critical level of diabetic autonomic neuropathy. Tohoku J Exp Med 141: 479–483, 1983.
18. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 3: 8–10, 2012.
19. Matsuo S, Imai E, Horio M, et al; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982–992, 2009.
20. Bacci S, Villella M, Villella A, et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: Applicability and accuracy of the exercise stress test. Eur J Endocrinol 147: 649–654, 2002.
21. Inoguchi T, Yamashita T, Umeda F, et al. High incidence of silent myocardial ischemia in elderly patients with non insulindependent diabetes mellitus. Diabetes Res Clin Pract 47: 37–44, 2000.
22. Djaberi R, Beishuizen ED, Pereira AM, et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 51: 1581–1593, 2008.
23. Upchurch CT, Barrett EJ. Screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab 97: 1434–1442, 2012.
24. Elliott A. Issues in medical exposures. J Radiol Prot 29: A107-A121, 2009.
25. Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 44: 923–930, 2004.
26. He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 101: 244–251, 2000.
27. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27: 713–721, 2006.
28. American Diabetes Association. Standards of medical care in diabetes-2012, Diabetes Care 35: S11-S63, 2012.
29. Young LH, Wackers FJ, Chyun DA, et al.; DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA 301: 1547–1555, 2009.